COTE, Michele L., Mei LIU, Stefano BONASSI, Monica NERI, Ann G. SCHWARTZ, David C. CHRISTIANI, Margaret R. SPITZ, Joshua E. MUSCAT, Gad RENNERT, Katja K. ABEN, Angeline S. ANDREW, Vladimir BENCKO, Heike BICKEBOELLER, Paolo BOFFETTA, Paul BRENNAN, Hermann BRENNER, Eric J. DUELL, Eleonora FABIANOVA, John K. FIELD, Lenka FORETOVÁ, Soren FRIIS, Curtis C. HARRIS, Ivana HOLCATOVA, Yun-Chul HONG, Dolores ISLA, Vladimir JANOUT, Lambertus A. KIEMENEY, Chikako KIYOHARA, Qing LAN, Philip LAZARUS, Jolanta LISSOWSKA, Loic LE MARCHAND, Dana MATES, Keitaro MATSUO, Jose I. MAYORDOMO, John R. MCLAUGHLIN, Hal MORGENSTERN, Heiko MUEELLER, Irene ORLOW, Bernard J. PARK, Mila PINCHEV, Olaide Y. RAJI, Hedy S. RENNERT, Peter RUDNAI, Adeline SEOW, Isabelle STUCKER, Neonila SZESZENIA-DABROWSKA, M. Dawn TEARE, Anne TJONNELAN, Donatella UGOLINI, Henricus F. M. VAN DER HEIJDEN, Erich WICHMANN, John K. WIENCKE, Penella J. WOLL, Ping YANG, David ZARIDZE, Zuo-Feng ZHANG, Carol J. ETZEL a Rayjean J. HUNG. Increased risk of lung cancer in individuals with a family history of the disease: A pooled analysis from the International Lung Cancer Consortium. European Journal of Cancer. Oxford, UK: ELSEVIER, 2012, roč. 48, č. 13, s. 1957-1968. ISSN 0959-8049. Dostupné z: https://dx.doi.org/10.1016/j.ejca.2012.01.038.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Increased risk of lung cancer in individuals with a family history of the disease: A pooled analysis from the International Lung Cancer Consortium
Autoři COTE, Michele L., Mei LIU, Stefano BONASSI, Monica NERI, Ann G. SCHWARTZ, David C. CHRISTIANI, Margaret R. SPITZ, Joshua E. MUSCAT, Gad RENNERT, Katja K. ABEN, Angeline S. ANDREW, Vladimir BENCKO, Heike BICKEBOELLER, Paolo BOFFETTA, Paul BRENNAN, Hermann BRENNER, Eric J. DUELL, Eleonora FABIANOVA, John K. FIELD, Lenka FORETOVÁ, Soren FRIIS, Curtis C. HARRIS, Ivana HOLCATOVA, Yun-Chul HONG, Dolores ISLA, Vladimir JANOUT, Lambertus A. KIEMENEY, Chikako KIYOHARA, Qing LAN, Philip LAZARUS, Jolanta LISSOWSKA, Loic LE MARCHAND, Dana MATES, Keitaro MATSUO, Jose I. MAYORDOMO, John R. MCLAUGHLIN, Hal MORGENSTERN, Heiko MUEELLER, Irene ORLOW, Bernard J. PARK, Mila PINCHEV, Olaide Y. RAJI, Hedy S. RENNERT, Peter RUDNAI, Adeline SEOW, Isabelle STUCKER, Neonila SZESZENIA-DABROWSKA, M. Dawn TEARE, Anne TJONNELAN, Donatella UGOLINI, Henricus F. M. VAN DER HEIJDEN, Erich WICHMANN, John K. WIENCKE, Penella J. WOLL, Ping YANG, David ZARIDZE, Zuo-Feng ZHANG, Carol J. ETZEL a Rayjean J. HUNG.
Vydání European Journal of Cancer, Oxford, UK, ELSEVIER, 2012, 0959-8049.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30200 3.2 Clinical medicine
Stát vydavatele Velká Británie a Severní Irsko
Utajení není předmětem státního či obchodního tajemství
Impakt faktor Impact factor: 5.061
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1016/j.ejca.2012.01.038
UT WoS 000307884500005
Klíčová slova anglicky Lung cancer; Familial aggregation
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Ing. Mgr. Věra Pospíšilíková, učo 9005. Změněno: 23. 4. 2014 15:58.
Anotace
Background and methods: Familial aggregation of lung cancer exists after accounting for cigarette smoking. However, the extent to which family history affects risk by smoking status, histology, relative type and ethnicity is not well described. This pooled analysis included 24 case-control studies in the International Lung Cancer Consortium. Each study collected age of onset/interview, gender, race/ethnicity, cigarette smoking, histology and first-degree family history of lung cancer. Data from 24,380 lung cancer cases and 23,305 healthy controls were analysed. Unconditional logistic regression models and generalised estimating equations were used to estimate odds ratios and 95% confidence intervals. Results: Individuals with a first-degree relative with lung cancer had a 1.51-fold increase in the risk of lung cancer, after adjustment for smoking and other potential confounders (95% CI: 1.39, 1.63). The association was strongest for those with a family history in a sibling, after adjustment (odds ratios (OR) = 1.82, 95% CI: 1.62, 2.05). No modifying effect by histologic type was found. Never smokers showed a lower association with positive familial history of lung cancer (OR = 1.25, 95% CI: 1.03, 1.52), slightly stronger for those with an affected sibling (OR = 1.44, 95% CI: 1.07, 1.93), after adjustment. Conclusions: The occurrence of lung cancer among never smokers and similar magnitudes of the effect of family history on lung cancer risk across histological types suggests familial aggregation of lung cancer is independent of those risks associated with cigarette smoking. While the role of genetic variation in the aetiology of lung cancer remains to be fully characterised, family history assessment is immediately available and those with a positive history represent a higher risk group. (c) 2012 Elsevier Ltd. All rights reserved.
VytisknoutZobrazeno: 14. 5. 2024 01:12